{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:16:22Z","timestamp":1760296582850},"reference-count":34,"publisher":"Wiley","issue":"s1","license":[{"start":{"date-parts":[[2008,8,18]],"date-time":"2008-08-18T00:00:00Z","timestamp":1219017600000},"content-version":"vor","delay-in-days":3121,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2000,2]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p> <jats:italic>Background<\/jats:italic>: Motility of <jats:italic>Helicobacter pylori<\/jats:italic> is essential for colonization. <jats:italic>H. pylori<\/jats:italic> has been shown to exhibit chemotactic activity toward urea and sodium and bicarbonate ions, which are secreted from the gastric epithelia. The importance of urease activity for chemotactic motility of <jats:italic>H. pylori<\/jats:italic> in a viscous environment has also been shown. Consequently, application of drugs inhibiting chemotactic motility has been proposed as a strategy for <jats:italic>H. pylori<\/jats:italic> eradication. This inhibitory effect can be evaluated through assay of chemotaxis and swarming.<\/jats:p><jats:p> <jats:italic>Materials and methods<\/jats:italic>: <jats:italic>H. pylori<\/jats:italic> CPY3401 and ATCC43504 were grown on brucella agar plates\/broth supplemented with 3% horse serum under microaerobic conditions (N<jats:sub>2<\/jats:sub>, 85%; O<jats:sub>2<\/jats:sub>, 5%; CO<jats:sub>2<\/jats:sub>, 10%). For motility assay, <jats:italic>H. pylori<\/jats:italic> cells grown on brucella\u2010serum agar were stabbed into motility agar containing 0.35% refined agar in brucella\u2010serum broth and the swarming zone was measured. For the chemotaxis assay, cells were suspended in 10\u2003m\n\t\t\t\t\t<jats:sc>m<\/jats:sc> potassium phosphate buffer, pH\u20037.0, with 3% polyvinyl\u2010 pyrrolidone and assayed as described previously. Bacterial swimming in the fluid environment was observed under dark\u2010field microscopy.<\/jats:p><jats:p> <jats:italic>Results<\/jats:italic>: Numbers of bacteria attracted toward 1\u2003\u03bc<jats:sc>m<\/jats:sc> flurofamide were reduced with increasing con\u2010 centrations of sofalcone (0.2\u2013222\u2003\u03bc<jats:sc>m<\/jats:sc>). In addition, the size of the swarming zone was reduced in motility agar containing 22 and 222\u2003\u03bc<jats:sc>m<\/jats:sc> sofalcone. On the other hand, 22\u2003\u03bc<jats:sc>m<\/jats:sc> sofalcone did not inhibit bacterial growth on day 3. Bacterial swimming speed in brucella broth was slower in the presence of 22 and 222\u2003\u03bc<jats:sc>m<\/jats:sc> sofalcone than in its absence.<\/jats:p><jats:p> <jats:italic>Conclusion<\/jats:italic>: Sofalcone was found to inhibit chemotactic motility of <jats:italic>H. pylori<\/jats:italic>. This drug may be useful for inhibiting the bacterium's ability to colonize the human stomach.<\/jats:p>","DOI":"10.1046\/j.1365-2036.2000.014s1230.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:42:17Z","timestamp":1047354137000},"page":"230-236","source":"Crossref","is-referenced-by-count":8,"title":["<i>A novel<\/i> in vitro <i>effect of the mucosal protective agent sofalcone \u2013 inhibition of chemotactic motility in<\/i> Helicobacter pylori"],"prefix":"10.1111","volume":"14","author":[{"given":"H.","family":"Yoshiyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Okita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,8,18]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1099\/00207713-39-4-397"},{"key":"e_1_2_6_3_2","first-page":"1273","article-title":"Unidentified curved bacilli on gastric epithelium in active chronic gastritis","author":"Warren JR","year":"1983","journal-title":"Lancet"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/153.4.658"},{"key":"e_1_2_6_5_2","first-page":"2067","article-title":"Helicobacter pylori infection enhances N\u2010methyl\u2010N\u2010nitrosourea\u2010induced stomach carcinogenesis in the Mongolian gerbil","volume":"58","author":"Sugiyama A","year":"1998","journal-title":"Cancer Res"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70143-X"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199405053301803"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)92035-Z"},{"key":"e_1_2_6_9_2","first-page":"8","article-title":"Current European concepts in the management of Helicobacter pylori infection","volume":"1","author":"European Helicobacter Pylori Study Group.","year":"1997","journal-title":"The Maastricht Concensus Report. Gut"},{"key":"e_1_2_6_10_2","first-page":"518","article-title":"Chemotaxis and motility of Helicobacter pylori in a viscous environment","volume":"34","author":"Yoshiyama H","year":"1999","journal-title":"J Gastroenterol"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.62.8.3586-3589.1994"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.62.9.3604-3607.1994"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.64.7.2817-2820.1996"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.10.4832-4837.1998"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-37-2-123"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1006\/jtbi.1995.0198"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1996.tb00041.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/aja.1001060305"},{"key":"e_1_2_6_19_2","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1128\/iai.65.4.1519-1521.1997","article-title":"Urease\u2010independent chemotactic response to urea, urease inhibitors, and sodium bicarbonate of Helicobacter pylori","volume":"65","author":"Mizote T","year":"1997","journal-title":"Infect Immun"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199800001-00030"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199800001-00031"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(84)90636-1"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1159\/000199507"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199700001-00028"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/37.5.919"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199001001-00023"},{"key":"e_1_2_6_27_2","first-page":"S121","article-title":"Effects of anti\u2010ulcer agents on antibiotic activity against Helicobacter pylori","volume":"6","author":"Sunairi M","year":"1994","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/PL00009960"},{"key":"e_1_2_6_29_2","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/ajcp\/54.6.828","article-title":"Automated micromeasurement of urea using urease and the Berthelot reaction","volume":"54","author":"Creno RJ","year":"1970","journal-title":"Am J Clin Pathol"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.1994.tb00433.x"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.175.11.3278-3288.1993"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.177.11.3010-3020.1995"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.26.5.831-836.1988"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.64.3.905-912.1996"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-60946-6_62"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.014s1230.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.014s1230.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2000.014s1230.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T13:38:31Z","timestamp":1695735511000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2000.014s1230.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,2]]},"references-count":34,"journal-issue":{"issue":"s1","published-print":{"date-parts":[[2000,2]]}},"alternative-id":["10.1046\/j.1365-2036.2000.014s1230.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2000.014s1230.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,2]]}}}